Medpace Aktie News

Medpace Holdings, Inc. (NASDAQ:MEDP ) Q1 2024 Earnings Call Transcript April 23, 2024 9:00 AM ET Company Participants Lauren Morris - Director of IR Jesse Geiger - President Kevin Brady - CFO August Troendle - CEO Conference Call Participants Max Smock - William Blair Eric Coldwell - Baird Jack Wallace - Guggenheim Partners Dan Leonard - UBS Justin Bowers - Deutsche Bank David Windley - Jefferi...

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Revenue for the three months ended March 31, 2024 increased 17.7% to $511.0 million, compared to $434.1 million for the comparable prior-year period. On a constant currency basis, revenue for the first q...

Uber, Axon and one more stock with the highest-possible rating from IBD lead this weekend's watch list.

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties mus...

Medpace Holdings, Inc. (MEDP) Q4 2023 Earnings Call Transcript

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Results Revenue for the three months ended December 31, 2023 increased 26.5% to $498.4 million, compared to $394.1 million for the comparable prior-year period. On a constant currency basis, r...

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2023 financial results after the market close on Monday, February 12, 2024. The Company will host a conference call the following morning, Tuesday, February 13, 2024, at 9:00 a.m. ET to discuss these results. To participate in the conference call,...

The pandemic pushed major biotech stocks into the spotlight as vaccine demands rose to unprecedented highs. Investors flocked to the industry in the next few years after the COVID-19 breakout.